✦ LIBER ✦

Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea

✍ Scribed by R. Brouard; T. Bossmar; D. Fournié-Lloret; D. Chassard; M. Åkerlund

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of SR 49059, an orally active V1

✍ Thomas Bossmar; Rémi Brouard; Anton Döberl; Mats Åkerlund 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

EFFECTS OF AN ORALLY ACTIVE VASOPRESSIN

✍ L. M. Burrell; P. A. Phillips; J. Stephenson; J. Risvanis; A-M. Hutchins; C. I. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

Pharmacological profile of SR 49059, a n

✍ C. Serradeil-Le Gal 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Effects of SR 49059, a non-peptide antag

✍ C Serradeil-Le Gal; G. Villanova; M. Boutin; JP Maffrand; G Le Fur 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Effects of Tolvaptan, an Oral Vasopressi

✍ Nicolaos E. Madias 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Effect of a new, potent, non-peptide V1a

✍ C.Serradeil-Le Gal; B. Bourrié; D. Raufaste; P. Carayon; C. Garcia; J.P. Maffran 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 931 KB